{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "07065 Administration of Antenatal steroids 6.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "ADMINISTRATION OF ANTENATAL STEROIDS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "07065"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "6.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, Obstetricians and Paediatricians"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "6 July 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "5 July 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Intrapartum NICE Guidelines RCOG guideline"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9,12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Miss Kausar, Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u25a1 MSE NHS Foundation Trust \u25a1 Basildon Hospital \u221a Broomfield Hospital \u25a1 Southend Hospital \u25a1 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Thakur, Clinical Director"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "12 May 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "29 June 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group"
                    },
                    {
                        "text": "Date: July 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "07065 Administration of Antenatal steroids 6.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 14,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "12 May 2020"
                    },
                    {
                        "text": "Mr Gangooly"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Partington"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Sharma"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Fiadjoe"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Joshi"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Amanda Dixon"
                    },
                    {
                        "text": "Matron for Inpatient Services"
                    },
                    {
                        "text": "Bernie O'Sullivan"
                    },
                    {
                        "text": "Lead Midwife for Day Assessment Unit"
                    },
                    {
                        "text": "Diane Wybro"
                    },
                    {
                        "text": "Lead Midwife for Antenatal Clinic"
                    },
                    {
                        "text": "Lavina D'Souza"
                    },
                    {
                        "text": "Matron for Antenatal Clinic"
                    },
                    {
                        "text": "Helen Ellis"
                    },
                    {
                        "text": "Pharmacist"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Guideline for Maternity Record Keeping 04232 High Dependency Care transfer to ITU 04234 Management of Postpartum Haemorrhage 09002 Management of Preterm Labour to Incorporate Administration of Intravenous Atosiban 07072 Management of a Patient Reporting Antepartum Haemorrhage 09044 Roles and responsibilities of staff when arranging an EL LSCS"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Julie Bishop"
                    },
                    {
                        "text": "Created"
                    },
                    {
                        "text": "October 2002"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Reviewed"
                    },
                    {
                        "text": "October 2007"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Front sheet, equality & Diversity; audit & monitoring"
                    },
                    {
                        "text": "May 2010"
                    },
                    {
                        "text": "2.2"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Clarification to point 5.3"
                    },
                    {
                        "text": "July 2010"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "November 2010"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Revision in light of RCOG antenatal steroid guidance. Audit and Monitoring update"
                    },
                    {
                        "text": "November 2011"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "Alex Field"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "November 2013"
                    },
                    {
                        "text": "5.0"
                    },
                    {
                        "text": "Sarah Moon"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "11th July 2017"
                    },
                    {
                        "text": "6.0"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Full Review to incorporate Preterm labour NICE guideline:NG25"
                    },
                    {
                        "text": "6 July 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose ....................................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment ..................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Indications for Antenatal Corticosteroids................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Timings for Antenatal Corticosteroids ...................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Cautions to the use of Corticosteroids ..................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Dosage and Route of Administration ........................................................................ 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Staff and Training ....................................................................................................... 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Professional Midwifery Advocates ............................................................................ 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Infection Prevention ................................................................................................... 6 10 Audit and Monitoring .................................................................................................. 6 11 Guideline Management\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20267 12 Approval and Implementation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20267 13 References\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u20268 Appendix 1: Preliminary Equality Analysis .................................................................. ...9"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Antenatal maternal administration of steroids in premature labour reduces the incidence of respiratory distress syndrome (RDS), necrotising enterocolitis and intra-ventricular haemorrhage in neonates resulting in reduced perinatal mortality and morbidity rates."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "RDS is known to affect 40-50% of babies born before 32 weeks gestation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The efficacy of neonatal surfactant therapy is enhanced by antenatal exposure to corticosteroids."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Clear benefits have been cited regarding the use of antenatal corticosteroids after prolonged premature rupture of membranes (PPROM)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "Most benefit is obtained in terms of reduced respiratory morbidity when delivery occurs between 24 hours and 7 days after administration of the second dose of steroids. Steroids should be given even if birth within 24 hours anticipated as they reduce neonatal death."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Indications for Antenatal Corticosteroids"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Antenatal corticosteroid therapy in patients should be initiated between 24 weeks to 34 weeks and 6 days gestation with any of the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "Threatened pre-term labour;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline for the \u2018Management of preterm labour to incorporate the   administration of intravenous atosiban'; register number 09002)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "Antepartum haemorrhage if considered to be at risk of preterm delivery;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline for the \u2018Management of a patient reporting antepartum"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "Haemorrhage'; register number 07072)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Preterm rupture of membranes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Patients undergoing elective Caesarean section prior to 39 weeks gestation should be offered a course of steroids to reduce neonatal respiratory morbidity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "Prophylactic corticosteroids should not be offered routinely to women with multiple pregnancy or history of previous preterm birth without signs of being at risk of preterm birth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "Pregnancies affected by fetal growth restriction between 24 weeks and 0 days gestation and 35 weeks and 6 days gestation at risk of delivery should receive a single course of antenatal corticosteroids."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Timings for Antenatal Corticosteroids"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "For women between 23+0 and 23+6 weeks of pregnancy who are in suspected or established preterm labour, are having a planned preterm birth or have P-PROM, discuss with the woman (and her family members or carers as appropriate) the use of maternal corticosteroids in the context of her individual circumstances. Consultant must be informed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Consider maternal corticosteroids for women between 24+0 and 25+6 weeks of pregnancy who are in suspected or established preterm labour, are having a planned preterm birth or have P-PROM."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Offer maternal corticosteroids to women between 26+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have P-PROM."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Offer maternal corticosteroids to women between 26+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have P-PROM."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "Consider maternal corticosteroids for women between 34+0 and 35+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have P-PROM."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "The risk of respiratory morbidity for infants delivered by elective caesarean section decreased by gestation compared with vaginal birth; (at 37 weeks of gestation OR 3.9 times higher with elective lower segment caesarean section (LSCS) over vaginal delivery with a 95% confidence interval 2.4\u20136.5; at 38 weeks of gestation OR 3.0 times higher with an elective LSCS over vaginal delivery with a 95% confidence interval 2.1\u20134.3; and 39 weeks of gestation OR 1.9 times higher with an elective LSCS over vaginal delivery with a 95% confidence interval 1.2\u20133.0)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "4.7. At MEHT the use of steroids prior to 39 weeks gestation will be assessed on an individual basis at the discretion of the obstetric consultant. The obstetric consultant requesting the steroids should be responsible for documenting the plan of care  in the woman's health care records and prescription chart."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Cautions to the Use of Corticosteroids"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "A single course of antenatal corticosteroids does not appear to cause any significant maternal or fetal effects."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Caution should be used when giving steroids to women with active tuberculosis or sepsis. Corticosteroids may be given in overt Chorioamnionitis but should not delay delivery if otherwise indicated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Maternal diabetes is not a contraindication to steroid administration but close monitoring of blood sugars with a low threshold for insulin sliding scale is recommended (liaise with the Diabetes Specialist Midwife."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Dosage and Route of Administration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Betamethasone is the steroid of choice to enhance lung maturation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Prophylaxis will take the form of a single course of:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Two doses of Betamethasone 12 mg, given intramuscularly (IM) 24 hours apart;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "text": "If delivery is expected within 12 hours, Betamethasone 12mg IM should be given at an interval of 12 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "In such circumstances where betamethasone is not available; dexamethasone can be administered in exactly the same dosage and route. Furthermore, if the first dose of betamethasone has been administered and subsequently becomes unavailable prior to the administration of the second dose; in this situation dexamethasone can be administered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Dose: Four doses of Dexamethasone 6mg, IM injection 12 hours apart."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "Repeat courses of the use of steroids"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "A repeat course of steroids should only be considered if the first dose was given before 26 weeks gestation and after discussion with a consultant obstetrician."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 1,
                "text": "6.4.1  Do not routinely offer repeat courses of maternal corticosteroids, but take into account:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "The interval since the end of last course;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "Gestational age;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "The likelihood of birth within 48 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Staff and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Midwives are qualified to undertake this by reasons of their professional training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Midwifery and medical students may administer the antenatal corticosteroid intramuscular injection under the supervision of the midwife or obstetrician respectively."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "When offering or considering maternal corticosteroids, discuss with the woman (and her family members or carers as appropriate):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "How corticosteroids may help;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "The potential risks associated with them."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Professional Midwifery Advocates"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Professional Midwifery Advocates provide a mechanism of support and guidance to women and midwives. Professional Midwifery Advocates are experienced practising midwives who have undertaken further education in order to supervise midwifery services and to advise and support midwives and women in their care choices."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention, using Aseptic Non-Touch Technique (ANTT) when carrying out this procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity annual audit work plan; to encompass national and local audit and clinical governance identifying key harm themes. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The findings of the audit will be reported to and approved by the Multi-disciplinary Risk Management Group (MRMG) and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The audit report will be reported to the monthly Directorate Governance Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Approval and Implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "All policies, procedures and guidelines will be circulated clinically and professional approval confirmed by the Asset Owner prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform appropriate Maternity Services' staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Obstetricians and Gynaecologists. (2010) Antenatal corticosteroids to reduce neonatal morbidity and mortality; Green-top Guideline 7; October; RCOG: London."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Crowther, C; Alfirevic, Z; Haslam, R. (2007) Thryotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews, 2007, no. 3 (CD000019)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "Preterm labour. NICE guideline [NG25] Published date: 20 November 2015 Last updated: 02 August 2019"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Administration of Antenatal Steroids/07065"
            }
        },
        {
            "type": "table",
            "sequence_num": 90,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "x"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year Review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 92,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "12/05/2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": ""
            }
        }
    ]
}